Probe of opioid-deal tax breaks urged

WASHINGTON -- Congress is calling on federal officials to review four large drug companies' plans to deduct the cost of a landmark opioid settlement from their taxes, after its year-long investigation into corporate disclosures first revealed in an analysis by The Washington Post.

Related Keywords

United States ,Washington ,Americans ,American ,Meryl Kornfield ,Matthew Gardner ,Erich Timmerman ,Jake Sargent ,Jessica Mayer ,Kevin Schaul ,Alexandra Lamanna ,Nicole Navas Oxman ,Institute On Taxation ,Amerisourcebergen ,Justice Department ,Treasury Department ,Mckesson ,Washington Post ,Cardinal Health ,Johnson ,House Committee On Oversight ,House Committee ,Navas Oxman ,